Victory Capital Management Inc. Increases Stock Holdings in CVS Health Corporation $CVS

Victory Capital Management Inc. increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,364,203 shares of the pharmacy operator’s stock after purchasing an additional 53,048 shares during the quarter. Victory Capital Management Inc. owned 0.11% of CVS Health worth $102,847,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of CVS Health in the second quarter valued at about $1,358,698,000. Invesco Ltd. lifted its position in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the period. Vanguard Group Inc. boosted its holdings in CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after purchasing an additional 2,063,737 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in CVS Health by 153.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,105,827 shares of the pharmacy operator’s stock worth $214,240,000 after purchasing an additional 1,878,217 shares during the period. Finally, Panagora Asset Management Inc. raised its stake in shares of CVS Health by 2,675.7% during the 2nd quarter. Panagora Asset Management Inc. now owns 1,116,742 shares of the pharmacy operator’s stock worth $77,033,000 after buying an additional 1,076,509 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 0.1%

Shares of CVS Health stock opened at $80.57 on Thursday. The business has a 50 day moving average price of $78.53 and a 200 day moving average price of $77.50. The company has a market capitalization of $102.50 billion, a P/E ratio of 58.38, a P/E/G ratio of 0.84 and a beta of 0.49. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter last year, the business posted $1.19 earnings per share. CVS Health’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is 192.75%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. The Goldman Sachs Group boosted their target price on shares of CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $91.00 price target on shares of CVS Health in a report on Tuesday, January 6th. TD Cowen raised their price objective on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Finally, UBS Group reissued an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.77.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.